A new drug being developed by local biotech company Aslan Pharmaceuticals may be able to provide those with eczema complete relief from their symptoms.
The company announced the enrolment of the first patient in its clinical trials yesterday.
Please subscribe or log in to continue reading the full article. Learn more about ST PREMIUM.
We have been experiencing some problems with subscriber log-ins and apologise for the inconvenience caused. Until we resolve the issues, subscribers need not log in to access ST Digital articles. But a log-in is still required for our PDFs.